Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2013

View Archived Issues

New small-molecule enzymatic inhibitors targeting primary human tumors

Adenovirus-based immunotherapy for chronic hepatitis B

New electrochemical immunosensor for diagnosis of inflammatory intestinal disease

Yakult Honsha synthesizes novel protein kinase inhibitors

French team presents new caspase activators

BioSavita and Quanta BioDesign enter collaboration to BioSuperior therapeutics

Dana-Farber and Evotec form oncology collaboration focusing on epigenetic targets

Servier to use Afraxis' ESP Technology for drug discovery

CCT-271850 demonstrates in vitro and in vivo activity

Tolero acquires worldwide license to Sanofi's alvocidib

OGX-427 to be studied as part of combination therapy for pancreatic cancer

Genentech evaluates antibody-drug conjugate for lung and ovarian cancer

Ligand acquires financial rights to portfolio of programs from Selexis

FDA approves use of Actemra in polyarticular juvenile idiopathic arthritis

FDA approves Raptor Pharmaceutical's treatment for nephropathic cystinosis

FDA issues complete response letter declining approval of Probuphine

Roche discloses new CRAC modulators

Novel PDE10A inhibitors prepared by Lundbeck

Enanta Pharmaceuticals synthesizes novel HCV NS5A inhibitors

Ascletis Pharmaceuticals obtains rights to HIV drug in China

DiaMedica begins first-in-human trial of DM-199

Forest Laboratories and Almirall report data from phase III AUGMENT COPD study

Daratumumab receives FDA breakthrough therapy designation

Vyvanse obtains FDA approval for maintenance treatment in children with ADHD

Omadacycline receives another QIDP designation

FDA committee votes against approval of tivozanib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...